Youqi Ji

Mr. Youqi Ji


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2025 in Molecules
Verified
Journal Article
Open access
PDF file
YJYouqi Ji
Youqi Ji
YWYinhuan Wang
Yinhuan Wang
ZXZhangkai Xu
Zhangkai Xu
DCDanlei Chen
Danlei Chen
ZYZhendi Yu
Zhendi Yu
DCDongqing Cheng
Dongqing Cheng
Background: Due to the widespread use of broad-spectrum antibiotics, the problem of antibiotic resistance has become an increasingly serious global threat. One of the key mechanisms of Escherichia coli resistance to beta-lactam antibiotics is the production of beta-lactamase enzymes, which poses a dilemma for clinicians in selecting antibiotics when faced with resistant bacterial infections. However, research on the reversal of bacterial resistance is limited. Methods: This study involved the preparation of Iris tectorum extract and detection of its effects on antibiotics sensitivity, extended-spectrum beta-lactamase (ESBL) gene expression, and histidine kinase phosphorylation levels in β-lactam antibiotic-resistant Escherichia coli. Additionally, analyses of the active ingredients of Iris tectorum extract were conducted with a liquid chromatography–mass spectrometer, and the binding sites were predicted by molecular docking. Results: Iris tectorum extract could restore the sensitivity of Escherichia coli to beta-lactam antibiotics and reduce the expression levels of ESBL genes and histidine phosphorylation levels. The active ingredients of Iris tectorum extract may be irigenin and tectorigenin, and these two small molecules could bind to histidine kinase to inhibit phosphorylation. Conclusions: Iris tectorum extract may serve as an antibiotic adjuvant, restoring the sensitivity of antibiotic-resistant bacteria by inhibiting histidine kinase phosphorylation, thereby alleviating the problem of Escherichia coli resistance to β-lactam antibiotics.

8 March 2025 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
XJXuxia Jiang
Xuxia Jiang
RLRui Lin
Rui Lin
SZShuilong Zhu
Shuilong Zhu
YJYouqi Ji
Youqi Ji
BZBingqian Zhuo
Bingqian Zhuo
YGYumei Ge
Yumei Ge
Introduction: Chlamydia psittaci is a rare zoonotic pathogen that can cause severe pneumonia. Due to its lack of specific clinical manifestations and limited clinical treatment experience, it is often missed or misdiagnosed. Case Presentation: We report a case of C. psittaci infection detected by metagenomic next-generation sequencing (m-NGS), aiming to provide a clinical reference for diagnosis and treatment. The patient presented with severe pneumonia caused by C. psittaci infection. Upon admission, the patient's condition was urgent, with blood oxygen saturation dropping to 88% and abnormal increases in white blood cells, high-sensitivity C-reactive protein, and inflammatory factors. Chlamydia psittaci was detected from bronchoalveolar lavage fluid using m-NGS, leading to an adjustment in the selection of antibiotics. After 18 days of continuous treatment, the patient recovered well. Conclusions: Metagenomic next-generation sequencing has significant application value in the detection of rare pathogens. It can quickly and accurately obtain detection results, guide medication, and assist in better treating patients.